Du DZ - Search Results

1

New construction for transversal design.

Du DZ, Hwang FK, Wu W, Znati T. Du DZ, et al. J Comput Biol. 2006 May;13(4):990-5. doi: 10.1089/cmb.2006.13.990. J Comput Biol. 2006. PMID: 16761923

2

Identifying d positive clones in the presence of inhibitors.

Du DZ, Hwang FK. Du DZ, et al. Int J Bioinform Res Appl. 2005;1(2):162-8. doi: 10.1504/IJBRA.2005.007575. Int J Bioinform Res Appl. 2005. PMID: 18048127

3

New constructions of one- and two-stage pooling designs.

Cheng Y, Du DZ. Cheng Y, et al. Among authors: du dz. J Comput Biol. 2008 Mar;15(2):195-205. doi: 10.1089/cmb.2007.0195. J Comput Biol. 2008. PMID: 18312150

4

Efficient constructions of disjunct matrices with applications to DNA library screening.

Cheng Y, Du DZ. Cheng Y, et al. Among authors: du dz. J Comput Biol. 2007 Nov;14(9):1208-16. doi: 10.1089/cmb.2007.0052. J Comput Biol. 2007. PMID: 17990978

5

On the parameterized complexity of pooling design.

Cheng Y, Du DZ, Ko KI, Lin G. Cheng Y, et al. Among authors: du dz. J Comput Biol. 2009 Nov;16(11):1529-37. doi: 10.1089/cmb.2008.0224. J Comput Biol. 2009. PMID: 19772384

6

Searching Genome-Wide Multi-Locus Associations for Multiple Diseases Based on Bayesian Inference.

Guo X, Zhang J, Cai Z, Du DZ, Pan Y. Guo X, et al. Among authors: du dz. IEEE/ACM Trans Comput Biol Bioinform. 2017 May-Jun;14(3):600-610. doi: 10.1109/TCBB.2016.2527648. Epub 2016 Feb 11. IEEE/ACM Trans Comput Biol Bioinform. 2017. PMID: 26887006

7

Production and genetic analysis of resynthesized Brassica napus from a B. rapa landrace from the Qinghai-Tibet Plateau and B. alboglabra.

Liu HD, Zhao ZG, Du DZ, Deng CR, Fu G. Liu HD, et al. Among authors: du dz. Genet Mol Res. 2016 Jan 8;15(1). doi: 10.4238/gmr.15017146. Genet Mol Res. 2016. PMID: 26909899 Free article.

8

Investigation of dry powder aerosolization mechanisms in different channel designs.

Chen L, Heng RL, Delele MA, Cai J, Du DZ, Opara UL. Chen L, et al. Among authors: du dz. Int J Pharm. 2013 Nov 30;457(1):143-9. doi: 10.1016/j.ijpharm.2013.09.012. Epub 2013 Sep 18. Int J Pharm. 2013. PMID: 24055441

9

A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma.

Zurita AJ, Jonasch E, Wang X, Khajavi M, Yan S, Du DZ, Xu L, Herynk MH, McKee KS, Tran HT, Logothetis CJ, Tannir NM, Heymach JV. Zurita AJ, et al. Among authors: du dz. Ann Oncol. 2012 Jan;23(1):46-52. doi: 10.1093/annonc/mdr047. Epub 2011 Apr 4. Ann Oncol. 2012. PMID: 21464158 Free PMC article. Clinical Trial.

10

Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer.

Hanrahan EO, Lin HY, Kim ES, Yan S, Du DZ, McKee KS, Tran HT, Lee JJ, Ryan AJ, Langmuir P, Johnson BE, Heymach JV. Hanrahan EO, et al. Among authors: du dz. J Clin Oncol. 2010 Jan 10;28(2):193-201. doi: 10.1200/JCO.2009.22.4279. Epub 2009 Nov 30. J Clin Oncol. 2010. PMID: 19949019 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page